Choriocarcinoma cell line resistance to NK lysis mainly involves an HLA-G-independent mechanism.
Avril
T
T
UPRES-JE 1992 Interactions Hôte-Greffon, Laboratoire d'Immunologie, Faculté de Médecine, Tours, France.
Jarousseau
A C
AC
Watier
H
H
Bardos
P
P
Thibault
G
G
D000906:Antibodies / Q000494:pharmacology; D015703:Antigens, CD / Q000276:immunology; D002822:Choriocarcinoma / Q000276:immunology* / Q000473:pathology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects / Q000502:physiology*; D006680:HLA Antigens / Q000502:physiology*; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I / Q000276:immunology / Q000502:physiology*; D007376:Interleukin-2 / Q000494:pharmacology; D015979:Killer Cells, Lymphokine-Activated / Q000502:physiology; D007694:Killer Cells, Natural / Q000502:physiology*; D037181:Lectins, C-Type; D008214:Lymphocytes / Q000187:drug effects / Q000502:physiology; D008562:Membrane Glycoproteins / Q000276:immunology; D051920:NK Cell Lectin-Like Receptor Subfamily D; D014407:Tumor Cells, Cultured
D000906:Antibodies; D015703:Antigens, CD; D006680:HLA Antigens; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I; D007376:Interleukin-2; D037181:Lectins, C-Type; D008562:Membrane Glycoproteins; D051920:NK Cell Lectin-Like Receptor Subfamily D